Vascular Health and Risk Management

Editor in Chief Professor Roland Asmar

Editorial: Incidence of stroke after myocardial infarction ||FREE PAPER||
Reza Tabrizchi

Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa
Todd W Rice

Noninvasive assessment of preclinical atherosclerosis
Helen A Lane, Jamie C Smith, J Stephen Davies

Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
Ryan C Neal, Peter H Jones

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?
Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, Gregory A Volturo

Ximelagatran: direct thrombin inhibitor
Shir-Jing Ho, Tim A Brighton

Insulin glargine in the treatment of type 1 and type 2 diabetes 59
Anthony H Barnett

Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
Catherine A Schnabel, Matthew Wintle, Orville Kolterman

Effects of eprosartan on target organ protection
Alejandro de la Sierra

Evaluation of efficacy and safety of fixed dose lovastatin and niacinER combination in Asian Indian dyslipidemic patients: a multicentric study
Manoj Sharma, Deepika R Sharma, Vikram Singh, RB Panwar, HS Hira, Bishav Mohan, Naveen Kumar, SK Sharma, Rajeev Gupta

Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
Journal Indexing
See where all the Dove Press journals are indexed